Manufacturer copay assistance · Herceptin Hylecta (J9356) · Genentech
$0 · Maximum benefit $25,000/year · Covers drug cost only — administration billed separately
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
No foundation fund in our catalog currently matches Herceptin Hylecta — check the full fund board.
Yes — Genentech Oncology Co-pay Assistance Program from Genentech. $0. Commercial insurance is required; Medicare and Medicaid patients are not eligible.
$0 Maximum benefit: $25,000/year. Covers drug cost only — administration billed separately
Accepted insurance: commercial. Not eligible: medicare, medicaid, government.